Cargando…
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
CONTEXT: Owing to the complexity of chemical ingredients in traditional Chinese medicine (TCM), it is difficult to maintain quality and efficacy by relying only on chemical markers. OBJECTIVE: Lianhua Qingwen capsule (LHQW) was selected as an example to discuss the feasibility of a bioassay for qual...
Autores principales: | Chen, Shuaishuai, Yang, Xiaojuan, Wei, Ziying, Zhang, Yanru, Huang, Ying, Shi, Zhuo, Zhang, Ziteng, Wang, Jiabo, Zhang, Haizhu, Ma, Jianli, Xiao, Xiaohe, Niu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110188/ https://www.ncbi.nlm.nih.gov/pubmed/33941036 http://dx.doi.org/10.1080/13880209.2021.1917627 |
Ejemplares similares
-
Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection
por: Gao, Dan, et al.
Publicado: (2020) -
Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity
por: Zhou, Yongfeng, et al.
Publicado: (2021) -
The mechanisms and clinical application of Traditional Chinese Medicine Lianhua-Qingwen capsule
por: Shen, Xuhui, et al.
Publicado: (2021) -
An umbrella review of Lianhua Qingwen combined with Western medicine for the treatment of coronavirus disease 2019
por: Yang, Kelu, et al.
Publicado: (2022) -
A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
por: Zhuang, Jieqin, et al.
Publicado: (2021)